October 2006 Issue of MMM
The big four-oh is, for most of us, a tough one, as birthdays go.
The following 40 people are innovators, creative geniuses, entrepreneurs, leaders, thinkers, doers...legends.
A chronology of medical agencies, from the founding firms through to the holding companies that now own them
We asked numerous industry executives for their thoughts on the most memorable campaigns from the past four decades of medical advertising.
Get acquainted with some of medical marketing's hottest prospects. Expect to read a lot more about them in the next 40 years.
While the focus of activity in pharmaceutical R&D has shifted from mass-market primary care drugs to specialty products, there are signs the long freeze on ...
We asked seven of the industry's greats to reflect on the past of pharmaceutical promotion. Their candid answers have much to say about the present ...
Pharmaceutical companies have not always done a good job of proving their value to the public.
The pharmaceutical industry is dealing with a vast array of critical issues that this readership knows all too well.
The entire communications services industry--clients, media owners and agencies alike--faces unprecedented challenges.
Helping people live longer, healthier, more productive lives: that's what America's pharmaceutical research companies do on a daily basis.
Whether you are a mainstay of medical marketing with an encyclopedic knowledge to boot, or you are just starting out in the field and could ...
It's hard to believe that when this publication appeared 40 years ago, Tylenol was a relatively new product and the Medicare program was fresh out ...
My father is over 80 years old. To look at his bulging waistline and to hear about his history of heart disease is to wonder ...
Med Ed Report
The 1990s are regarded as one of the most positive decades for CME.
The stage is set for grantors and providers to continue evolving the quality of programming and their compliance with regulation during the next 40 years.
It was simpler in the days, before DTC and CME and a host of other acronyms crept into the mix.
The proliferation of available marketing channels--those targeting physicians as well as other audiences--has many in the medical publishing world convinced that the day of the ...
Pharma e-marketers have the Cold War to thank for their craft.
E-marketing has progressed into a way for marketers to differentiate themselves based on experience with their customers and as a viable means to be able ...
Lester Wunderman is credited with being the driving force behind direct marketing as it is known today, with his theories an integral part of the ...
As the mass marketing approach has become considered increasingly less effective, CRM and direct-to-patient initiatives are being thrust to the forefront of pharma marketers' efforts.
Claritin, approved in 1993 and launching DTC in 1995, wasn't the first big brand advertised to consumers, but it was the first really huge spender ...
After a period of soul-searching, a renewed commitment to self-regulation and a plague of doctors in TV ads, DTC seems to have survived the fallout ...
Corporate reputation can be a fickle thing—particularly in pharma.
Pharma marketers are seldom early adopters when it comes to cutting-edge promotional techniques and new technologies.
MM&M's 40th anniversary called to mind that one of my first articles for the magazine--not quite 40 years ago but close--was about the emergence of ...
- The 2017 pipeline report: What to know about next year's launches
- Five things for pharma marketers to know: Monday, November 28, 2016
- Lilly's branded app for Trulicity looks to address adherence
- Lawmakers cut CME exemption from 21st Century Cures Act
- Five things for pharma marketers to know: Tuesday, November 29, 2016
- Boehringer Ingelheim launches gamified support program
- Omnicom merges AgencyRx, Flashpoint and three other agencies to form DDB Health
- No free lunch for docs: Sponsored meals linked to more prescriptions
- Non-profit behind Free Killer Tan wants parents to practice sun safety
- Allergan draws on A-list celebs to drive engagement
- Prescription drug spending rises 9% in 2015, to $324 billion
- As users move to mobile, Google says they made 200 million queries for info about cancer drugs
- Five things for pharma marketers to know: Friday, December 2, 2016
- Mylan CEO defends EpiPen strategy, questions pricing model in the U.S.
- Five things for pharma marketers to know: Thursday, December 1, 2016